PolyPeptide Group AG (PPGN) — Net Asset Momentum
PolyPeptide Group AG (PPGN) recorded a net asset momentum of -6.3% as of December 2024, with net assets of CHF357.24 Million CHF. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See PPGN defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
PolyPeptide Group AG Net Asset Momentum (2018–2024)
This chart tracks PolyPeptide Group AG's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is -6.3%, with net assets of CHF357.24 Million CHF as of December 2024. Read PolyPeptide Group AG (PPGN) financial obligations for a breakdown of total debt and financial obligations.
Annual Net Asset History for PolyPeptide Group AG (2018–2024)
The table below shows the complete annual net asset history for PolyPeptide Group AG from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see PolyPeptide Group AG market capitalisation.
| Year | Net Assets (CHF) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | CHF357.24 Million | CHF756.58 Million | CHF399.33 Million | ▼ -6.3% |
| 2023 | CHF381.23 Million | CHF689.09 Million | CHF307.86 Million | ▼ -9.6% |
| 2022 | CHF421.68 Million | CHF575.78 Million | CHF154.10 Million | ▲ +0.1% |
| 2021 | CHF421.17 Million | CHF595.04 Million | CHF173.87 Million | ▲ +137.1% |
| 2020 | CHF177.66 Million | CHF375.98 Million | CHF198.31 Million | ▲ +18.9% |
| 2019 | CHF149.42 Million | CHF305.14 Million | CHF155.73 Million | ▲ +1.2% |
| 2018 | CHF147.67 Million | CHF283.83 Million | CHF136.15 Million | — |